Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Ferdinando Stelio Buonanno, M.D.

Co-Author

This page shows the publications co-authored by Ferdinando Buonanno and Eng Lo.
Connection Strength

1.286
  1. Pharmaco-proteomics opportunities for individualizing neurovascular treatment. Neurol Res. 2013 Jun; 35(5):448-56.
    View in: PubMed
    Score: 0.139
  2. The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease. Pharmacol Ther. 2013 Aug; 139(2):111-23.
    View in: PubMed
    Score: 0.137
  3. Application of proteomics to cerebrovascular disease. Electrophoresis. 2012 Dec; 33(24):3582-97.
    View in: PubMed
    Score: 0.134
  4. Proteomic temporal profile of human brain endothelium after oxidative stress. Stroke. 2011 Jan; 42(1):37-43.
    View in: PubMed
    Score: 0.117
  5. Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside. Transl Stroke Res. 2010 Dec 01; 1(4):268-75.
    View in: PubMed
    Score: 0.117
  6. Effect of Patent Foramen Ovale Closure After Stroke on Circulatory Biomarkers. Neurology. 2021 07 13; 97(2):e203-e214.
    View in: PubMed
    Score: 0.060
  7. Reply: Shouldn't Patients With Paradoxical Emboli and Thrombophilia Be Given Anticoagulant Agents? JACC Cardiovasc Interv. 2021 03 08; 14(5):583-584.
    View in: PubMed
    Score: 0.059
  8. Patent Foramen Ovale Attributable Cryptogenic Embolism With Thrombophilia Has Higher Risk for Recurrence and Responds to Closure. JACC Cardiovasc Interv. 2020 12 14; 13(23):2745-2752.
    View in: PubMed
    Score: 0.058
  9. Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence. Ann Intern Med. 2020 12 01; 173(11):946-947.
    View in: PubMed
    Score: 0.058
  10. Dual antiplatelet therapy reduced stroke risk in transient ischemic attack with positive diffusion weighted imaging. Sci Rep. 2020 11 05; 10(1):19132.
    View in: PubMed
    Score: 0.058
  11. Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence: A Prospective Cohort Study. Ann Intern Med. 2020 06 02; 172(11):717-725.
    View in: PubMed
    Score: 0.056
  12. Efficacy of High-intensity Statin Use for Transient Ischemic Attack Patients with Positive Diffusion-weighted Imaging. Sci Rep. 2019 02 04; 9(1):1173.
    View in: PubMed
    Score: 0.051
  13. Plasma Glycoproteomic Study of Therapeutic Hypothermia Reveals Novel Markers Predicting Neurologic Outcome Post-cardiac Arrest. Transl Stroke Res. 2018 02; 9(1):64-73.
    View in: PubMed
    Score: 0.046
  14. Patent foramen ovale (PFO), stroke and pregnancy. J Investig Med. 2016 06; 64(5):992-1000.
    View in: PubMed
    Score: 0.042
  15. Proteomic signatures of serum albumin-bound proteins from stroke patients with and without endovascular closure of PFO are significantly different and suggest a novel mechanism for cholesterol efflux. Clin Proteomics. 2015; 12(1):2.
    View in: PubMed
    Score: 0.039
  16. Heart-brain signaling in patent foramen ovale-related stroke: differential plasma proteomic expression patterns revealed with a 2-pass liquid chromatography-tandem mass spectrometry discovery workflow. J Investig Med. 2012 Dec; 60(8):1122-30.
    View in: PubMed
    Score: 0.033
  17. Discrimination of ischemic and hemorrhagic strokes using a multiplexed, mass spectrometry-based assay for serum apolipoproteins coupled to multi-marker ROC algorithm. Proteomics Clin Appl. 2012 Apr; 6(3-4):190-200.
    View in: PubMed
    Score: 0.032
  18. Cerebral edema and a transtentorial brain herniation syndrome associated with pandemic swine influenza A (H1N1) virus infection. J Clin Neurosci. 2011 Sep; 18(9):1245-8.
    View in: PubMed
    Score: 0.030
  19. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke. 2005 Apr; 36(4):797-802.
    View in: PubMed
    Score: 0.020
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.